Early Careers
Early Careers
Search
Corporate Strategy & Consulting
Corporate Strategy & Consulting
Gastrointestinal Cancers
Gastrointestinal Cancers
Swine
Swine
Patient Centricity
Patient Centricity
Media Overview
Media Overview
Clinical Studies
Clinical Studies
Metabolic Diseases
Metabolic Diseases
Biopharma Contract Manufacturing
Biopharma Contract Manufacturing
Growing with us
We recognize the benefits of learning and have created an environment where life-long learning and personal growth are encouraged for all employees.
Sites Around the World
Sites Around the World
Across Cancer Types
Across Cancer Types
Heart Diseases
Heart Diseases
A professional family
We believe that great teams are made up of people who are happy, fulfilled and have a sense of purpose. Flexibility and work/life balance are highly valued.
Social media community guidelines
Social media community guidelines
Accessible Customer Service Policy
Accessible Customer Service Policy
PIPEDA Terms of Use Consent - Contact us form - english
PIPEDA Terms of Use Consent - Contact us form - english
Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales) More than 25 billion EUR investment in R&D and 7 billion EUR in capital expenditure over the next five years Human Pharma pipeline acceleration: up to 15 new product launches
Diabetes
Diabetes
Dr. Todd Duffield named as the 2018 Metacam® 20* Bovine Welfare Award winner
Dr. Todd Duffield named as the 2018 Metacam® 20* Bovine Welfare Award winner
About Us
About Us
Boehringer Ingelheim reaches more patients than ever in 2022 as innovative medicines drive growth
• Medicines reached a record 30 million people, driven by JARDIANCE® and OFEV® • R&D investments of 5 billion EUR, or 21 percent of net sales • Net sales rise 10.5 percent (currency adjusted), up strongly to 24.1 billion EUR
First Half of 2022: Boehringer Ingelheim continues growth pace and strengthens research pipeline
Growing late-stage research pipeline, addressing areas of high unmet medical need Pipeline includes areas such as rare skin disease, pulmonary fibrosis, oncology and central nervous system disease Net sales rise currency-adjusted by 9.5 percent to 11.
Laura loves her diverse career
Laura loves her diverse career at Boehringer Ingelheim. For more talent insights, visit our Careers Page.
Dirk Stenkamp
Dirk Stenkamp, Senior Vice President Research Site Germany, reflects on our culture of collaboration and passion for progress.